Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heart failure
Marco Metra, John R. Teerlink
The Lancet (2017) Vol. 390, Iss. 10106, pp. 1981-1995
Closed Access | Times Cited: 562

Showing 1-25 of 562 citing articles:

Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis
Xuexian Fang, Zhaoxian Cai, Hao Wang, et al.
Circulation Research (2020) Vol. 127, Iss. 4, pp. 486-501
Open Access | Times Cited: 565
Single-cell reconstruction of the adult human heart during heart failure and recovery reveals the cellular landscape underlying cardiac function
Li Wang, Yu Peng, Bingying Zhou, et al.
Nature Cell Biology (2020) Vol. 22, Iss. 1, pp. 108-119
Closed Access | Times Cited: 350
Excess Mortality Associated With Functional Tricuspid Regurgitation Complicating Heart Failure With Reduced Ejection Fraction
Giovanni Benfari, Clémence Antoine, Wayne L. Miller, et al.
Circulation (2019) Vol. 140, Iss. 3, pp. 196-206
Open Access | Times Cited: 302
Cardiomyopathy in obesity, insulin resistance and diabetes
Michinari Nakamura, Junichi Sadoshima
The Journal of Physiology (2019) Vol. 598, Iss. 14, pp. 2977-2993
Open Access | Times Cited: 215
The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study
William G. Herrington, David Preiss, Richard Haynes, et al.
Clinical Kidney Journal (2018) Vol. 11, Iss. 6, pp. 749-761
Open Access | Times Cited: 212
The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure
Ahmad A. Cluntun, Rachit Badolia, Sandra Lettlová, et al.
Cell Metabolism (2020) Vol. 33, Iss. 3, pp. 629-648.e10
Open Access | Times Cited: 212
Celastrol Attenuates Angiotensin II–Induced Cardiac Remodeling by Targeting STAT3
Shiju Ye, Wu Luo, Zia A. Khan, et al.
Circulation Research (2020) Vol. 126, Iss. 8, pp. 1007-1023
Open Access | Times Cited: 196
Rapamycin regulates the balance between�cardiomyocyte apoptosis and autophagy in chronic heart failure by inhibiting mTOR signaling
Guangyuan Gao, Weiwei Chen, Mengjie Yan, et al.
International Journal of Molecular Medicine (2019)
Open Access | Times Cited: 182
DYRK1B-STAT3 Drives Cardiac Hypertrophy and Heart Failure by Impairing Mitochondrial Bioenergetics
Lingfang Zhuang, Kangni Jia, Chen Chen, et al.
Circulation (2022) Vol. 145, Iss. 11, pp. 829-846
Open Access | Times Cited: 110
Pre‐discharge and early post‐discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC
Marco Metra, Marianna Adamo, Daniela Tomasoni, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 7, pp. 1115-1131
Open Access | Times Cited: 40
Association between haemoglobin, albumin, lymphocytes, and platelets and mortality in patients with heart failure
Ling Liu, Benbingdi Gong, Wei Wang, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 2, pp. 1051-1060
Open Access | Times Cited: 15
ChatGPT and Patients With Heart Failure
Fotis Dimitriadis, Stelina Alkagiet, Lamprini Tsigkriki, et al.
Angiology (2024)
Closed Access | Times Cited: 15
Lean Mass Abnormalities in Heart Failure: The Role of Sarcopenia, Sarcopenic Obesity, and Cachexia
Salvatore Carbone, Hayley Billingsley, Paula Rodriguez‐Miguelez, et al.
Current Problems in Cardiology (2019) Vol. 45, Iss. 11, pp. 100417-100417
Open Access | Times Cited: 135
Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction
John R. Teerlink, Rafael Díaz, G. Michael Felker, et al.
JACC Heart Failure (2020) Vol. 8, Iss. 4, pp. 329-340
Open Access | Times Cited: 119
Gene Therapy for the Heart Lessons Learned and Future Perspectives
Antonio Cannatà, Hashim Ali, Gianfranco Sinagra, et al.
Circulation Research (2020) Vol. 126, Iss. 10, pp. 1394-1414
Open Access | Times Cited: 116
Effectiveness of pharmacist’s intervention in the management of cardiovascular diseases
Stefano Omboni, Marina Caserini
Open Heart (2018) Vol. 5, Iss. 1, pp. e000687-e000687
Open Access | Times Cited: 112
Distinct Phenotypes Induced by Three Degrees of Transverse Aortic Constriction in Mice
Daniel A. Richards, Mark Aronovitz, Timothy D. Calamaras, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 111
Establishment of a heart-on-a-chip microdevice based on human iPS cells for the evaluation of human heart tissue function
Mosha Abulaiti, Yaxiaer Yalikun, Kozue Murata, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 109
An updated role of astragaloside IV in heart failure
Yibei Zang, Jingjing Wan, Zhen Zhang, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 126, pp. 110012-110012
Open Access | Times Cited: 92
Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure
Michele Emdin, Alberto Aimo, Vincenzo Castiglione, et al.
Journal of the American College of Cardiology (2020) Vol. 76, Iss. 15, pp. 1795-1807
Closed Access | Times Cited: 88
Temporal trends in mortality and readmission after acute heart failure: a systematic review and meta‐regression in the past four decades
Antoine Kimmoun, Koji Takagi, Emmanuel Gall, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 3, pp. 420-431
Open Access | Times Cited: 87
‘Time is prognosis’ in heart failure: time‐to‐treatment initiation as a modifiable risk factor
Amr Abdin, Stefan D. Anker, Javed Butler, et al.
ESC Heart Failure (2021) Vol. 8, Iss. 6, pp. 4444-4453
Open Access | Times Cited: 77
Cardiomyocyte Proliferation and Maturation: Two Sides of the Same Coin for Heart Regeneration
Ming‐Tao Zhao, Shiqiao Ye, Juan Su, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 71
Histochrome Attenuates Myocardial Ischemia-Reperfusion Injury by Inhibiting Ferroptosis-Induced Cardiomyocyte Death
Ji-Won Hwang, Jae-Hyun Park, Bong‐Woo Park, et al.
Antioxidants (2021) Vol. 10, Iss. 10, pp. 1624-1624
Open Access | Times Cited: 60
Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease: a machine learning approach
Karolina Drożdż, Katarzyna Nabrdalik, Hanna Kwiendacz, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 57
Page 1 - Next Page

Scroll to top